Hillsdale Investment Management Inc. Invests $976,000 in HCA Healthcare, Inc. $HCA

Hillsdale Investment Management Inc. bought a new position in HCA Healthcare, Inc. (NYSE:HCA) in the 4th quarter, Holdings Channel.com reports. The fund bought 2,090 shares of the company’s stock, valued at approximately $976,000.

Several other large investors also recently added to or reduced their stakes in the business. Triglav Investments D.O.O. grew its position in HCA Healthcare by 7.4% in the fourth quarter. Triglav Investments D.O.O. now owns 2,148 shares of the company’s stock worth $1,003,000 after acquiring an additional 148 shares in the last quarter. Fideuram Asset Management Ireland dac bought a new stake in HCA Healthcare in the fourth quarter worth approximately $1,551,000. Principia Wealth Advisory LLC lifted its stake in shares of HCA Healthcare by 2,900.0% in the fourth quarter. Principia Wealth Advisory LLC now owns 210 shares of the company’s stock worth $98,000 after buying an additional 203 shares during the last quarter. Basepoint Wealth LLC acquired a new stake in shares of HCA Healthcare in the fourth quarter worth $35,000. Finally, Rothschild Investment LLC lifted its stake in shares of HCA Healthcare by 3.4% in the fourth quarter. Rothschild Investment LLC now owns 788 shares of the company’s stock worth $368,000 after buying an additional 26 shares during the last quarter. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Stock Down 2.1%

Shares of HCA Healthcare stock opened at $370.77 on Tuesday. The stock has a market capitalization of $82.25 billion, a P/E ratio of 12.75, a price-to-earnings-growth ratio of 1.20 and a beta of 1.12. The company has a 50-day simple moving average of $449.37 and a 200 day simple moving average of $480.24. HCA Healthcare, Inc. has a 12-month low of $330.00 and a 12-month high of $556.52.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). The firm had revenue of $19.11 billion for the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The company’s revenue for the quarter was up 4.3% compared to the same quarter last year. During the same quarter last year, the business earned $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities analysts anticipate that HCA Healthcare, Inc. will post 30.07 earnings per share for the current year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be given a dividend of $0.78 per share. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. HCA Healthcare’s dividend payout ratio (DPR) is 10.73%.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the stock. Royal Bank Of Canada reduced their price objective on shares of HCA Healthcare from $593.00 to $534.00 and set an “outperform” rating for the company in a research note on Monday, April 27th. Deutsche Bank Aktiengesellschaft cut their target price on shares of HCA Healthcare from $558.00 to $540.00 and set a “buy” rating for the company in a research note on Tuesday, April 28th. UBS Group upped their target price on shares of HCA Healthcare from $598.00 to $635.00 and gave the company a “buy” rating in a research note on Monday, February 23rd. Truist Financial cut their target price on shares of HCA Healthcare from $546.00 to $535.00 and set a “buy” rating for the company in a research note on Monday, April 27th. Finally, Wells Fargo & Company cut their target price on shares of HCA Healthcare from $481.00 to $436.00 and set an “equal weight” rating for the company in a research note on Monday, April 27th. Sixteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, HCA Healthcare presently has an average rating of “Moderate Buy” and an average target price of $515.77.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.